July 21, 2014 / With four separate revenue drivers, a unique first-of-its-kind technology, an individual proprietary cannabis strains and a presence within a growing list of states, GrowBLOX Sciences, Inc. has been garnering the attention of the investment community over the last few months. Not only has GBLX seen explosive highs nearly $3.50, but the recent pullback to lows of $1 may have opened an opportunity for new investment. After watching the trading from Friday’s afternoon session, a deeper look at the company and the current industry climate are the main reasons for wanting to keep an eye on this company heading into the rest of the month.
The company's technology has been built to set the standard for manufacturing and medical cannabis producing technology, and has it positioned to become a key player in the industry. Back in May, GBLX identified one of its major revenue drivers would be partnering with in-state growers to help them cultivate cannabis that meets patients' needs. To this point, the company has entered into several key markets:
GBLX became one of the "chosen 18" that were granted special use permit licenses for medical marijuana dispensaries through its local partnership, GBS NEVADA, LLC. The Company's Fort Apache location is the only dispensary to service the needs of patients in that area, giving GBLX a major advantage in the Nevada market.
Mid July marked GBLX’s entry into the Florida market through its wholly owned subsidiary, GB Sciences Florida, LLC. The National Cannabis Industry Association estimates medical marijuana will be a $785 million industry in Florida with multiple economic opportunities. Governor Rick Scott signed a law on June 16 allowing for the limited use of a special strain of marijuana called "Charlotte's Web" to treat those suffering from epilepsy, cancer and amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease and this is just the first step for the state. Florida will have the opportunity to enact a comprehensive, workable medical marijuana law this November by voting yes on Amendment Two.
GrowBLOX is currently involved in the application process for licensing in Illinois. As far as timing goes, GBLX has acted quickly in preparation of the potential move as state lawmakers have set final rules to allow medical marijuana in Illinois. Door would be open for patients to apply for ID cards this fall and to start purchasing legal cannabis by next spring. The state intends to approve a total of 21 licenses for cultivation and 60 for dispensaries by September. According to the Marijuana Business Factbook, the IL market hosts some 10,000 patients and will generate anywhere from $25 million to $45 million in cannabis sales.
The Company opened its subsidiary GB Sciences Puerto Rico, Inc. and is monitoring the island's pending legislation to legalize medical marijuana. The Puerto Rican Senate is currently discussing the legalization of marijuana for medical use and its cultivation and so far SB 517 has passed senate in a 14-12 vote now moving on to the House; it would decriminalize up to 14 grams of marijuana. As far as legalization of medical, Representative Carlos Vargas introduced House Bill 1362 to legalize medical marijuana and regulate its sale, possession and consumption. During the public hearings on House Bill 1362, most groups testified in favor of medical marijuana and argued similar cases as other states moving forward with a motion to legalize the medical use of the drug identifying that reform is needed to tackle drug addiction and high incarceration rates.
With GBLX already set up in Nevada and already establishing a presence in 3 more areas positioned for some type of legalization, the company has significantly entrenched itself as a driving force within the industry as a whole. Beyond the cultivation aspect, the company has also put into place, key relationships with banking and inside investment. Lazarus Investment Partners LLLP, has acquired an additional 269,632 shares in the open market for an additional $322,000 investment. Lazarus, which already holds a 3,000,000-share investment, which actually averaged UP their position in GrowBLOX. I’m sure it’s not hard to see that by averaging up, the firm believes that this is an undervalued investment under the $1.20 mark.
Furthermore, and quite possibly even more important is a two-fold chain of events: 1. GBLX secured a letter of intent with First Security Bank of Nevada for the purpose of managing the currency and banking flow of The Company's operating facilities and 2. The House voted Wednesday (7/16) in a 236-186 win in support of making it easier for banks to do business with legal pot shops and providers of medical marijuana. This was a decision that rejected a move by Rep. John Fleming, R-La., to block the Treasury Department from implementing guidance it issued in February telling banks how to report on their dealings with marijuana-related businesses without running afoul of federal money-laundering laws. The Treasury guidance was intended to give banks confidence that they can deal with marijuana businesses in states where they're legal. For marijuana cultivation companies like GrowBLOX in connection with its LOI puts GBLX in place to immediately benefit from the previously signed LOI moving forward with full access to banking operations as it stands today.
There’s no doubt that the US is moving toward a new industry explosion. Sentiment from the quickly growing millennial generation is in clear support for full legalization. Americans age 18 to 29 oppose the federal prohibition of marijuana, according to national polling data compiled by the Reason Foundation. In addition to this, of those polled, only 14 percent said that someone who consumes marijuana should go to jail. So as more states continue to move toward some form of legalization not only has GBLX positioned itself ahead of these motions through subsidiaries and partnerships, but it has also been incredibly active in providing the necessary quality that many medical programs are looking for.
Although GBLX has gone through a consolidation over the past week, it looks like interest has built once again following announcements from Capitol Hill in addition to the companies continued growth in additional markets like Illinois and Florida so heading into the week ahead, this is going to be a stock that I will be watching very closely especially after the late afternoon activity from Friday.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOXTM chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, physicians and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.